ArticleSurgical endoscopy2026
Real-time indocyanine green fluorescence imaging enhances the precision of lymph node dissection in laparoscopic colon cancer surgery: a propensity score-matched cohort study.
Article in Surgical endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundComplete mesocolic excision and D3 lymphadenectomy are essential for curative colon cancer surgery. However, identifying the optimal mesenteric dissection plane remains challenging. Near-infrared (NIR) fluorescence imaging using indocyanine green (ICG) enables real-time visualization of lymphatic flow, potentially enhancing surgical precision. This study aimed to evaluate the utility of ICG-NIR fluorescence guidance for precise lymph node dissection during laparoscopic colectomy for colon cancer.
methodsPatients with stage II-III colon cancer who underwent laparoscopic colectomy with D3 lymphadenectomy, with (NIR group, n = 62) or without (non-NIR group, n = 65) ICG guidance, were retrospectively compared using propensity score matching. ICG (2.5 mg/mL) was injected submucosally near the tumor preoperatively. Fluorescent lymph nodes were identified and dissected intraoperatively. Outcomes included 3-year relapse-free survival, total and apical lymph node yields, blood loss, and postoperative complications.
resultsAfter propensity score matching, 50 patients were included in each group. The total lymph node yield tended to be higher in the NIR group (27.6 ± 11.3 vs. 23.4 ± 9.4; p = 0.052), whereas the number of apical lymph nodes harvested was significantly greater (6.8 ± 4.3 vs. 3.3 ± 2.5; p < 0.001). Operative time was comparable between groups (315 [178-934] vs. 291.5 [146-521] min; p = 0.236), whereas estimated blood loss was significantly lower in the NIR group (5 [5-220] vs. 60 [5-825] mL; p < 0.001). Postoperative complications occurred less frequently in the NIR group (6 vs. 16%, p = 0.200). The 3-year relapse-free survival rates were 80.5% in the NIR group and 80.1% in the non-NIR group (p = 0.934).
conclusionICG-NIR fluorescence-guided laparoscopic colectomy enhances the precision of lymph node dissection and mesocolic excision, increases apical lymph node yield, and may improve surgical safety and efficiency. However, no survival advantage was observed.
Indexed as
Identifiers
42301453What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.